Biotangents secure funding to develop next generation mastitis testing

14 December 2020

Biotangents have been awarded seed funding from CIEL (Centre for Innovation Excellence in Livestock) to work with researchers at the University of Edinburgh Roslin Institute as part of our development of an in-clinic and on-farm diagnostic for Mastitis. This will differentiate between key mastitis-causing pathogens, meeting a critical industry-led need.


Mastitis is an inflammation of the mammary gland that is predominantly caused by a bacterial infection and is the most common and costly disease affecting the dairy industry. Because it can cause significant financial losses and adversely impact animal welfare, farmers and herd managers need quick diagnostic results so they can take fast and appropriate action.


In this project, researchers from the Roslin Institute will produce gene expression data for mastitis-causing pathogens and identify the most prevalent causes of mastitis in the UK, and also globally to meet our future international sales. This data will be used by our multi-disciplinary team, to develop the next generation of mastitis diagnostics.


This latest Biotangents innovation, for new diagnostic solutions for use in-clinic and on-farm, with global application, delivers the following benefits:




Copyright © 2019 Biotangents Limited. All rights reserved. 

Registered company number: SC495625. VAT Number: GB 219 8525 83.

Registered company and trading address: Douglas House, Pentlands Science Park, Bush Loan, Penicuik, Midlothian, Scotland EH26 0PZ.